Clinical trial
A Prospective, Multi-centers, Randomized,Controlled, Blinded,Superiority Trial of Renal Denervation Using Iberis MultiElectrode Renal Denervation System for the Treatment of Primary Hypertension.
NCT02901704 is registered in ClinicalTrials.gov with Shanghai AngioCare Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-centers, Randomized,Controlled, Blinded,Superiority Trial of Renal Denervation Using Iberis MultiElectrode Renal Denervation System for the Treatment of Primary Hypertension.
- Lead sponsor
- Shanghai AngioCare Medical
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- December 31, 2016
- Completion date
- December 31, 2018
- Enrollment
- 216 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
primary hypertension